The European Immunogenicity Platform acts as a central meeting place for European biopharmaceutical companies and scientific experts active in the field of immunogenicity.
Its scope is:
Interaction with authorities regarding immunogenicity guidelines
Formulate active recommendations regarding immunogenicity
Stimulate research addressing the clinical and non-clinical effects of unwanted immunogenicity
Collaboration between academia and pharmaceutical companies,
The European Immunogenicity Platform aims to build a broad knowledge-base related to immunogenicity, and to stimulate interactions and developments in the broad field of immunogenicity.
Through its working-group structure, the EIP can react in a focused way on regulatory and scientific evolutions in the immunogenicity-field. The European Immunogenicity Platform was created early 2007 by experts in the field of immunogenicity.
Program of the 2016 conference will be published end of October 2015.